#$DNTH
Bain Capital Life Sciences Investors – Q3 2026 13F Update

• Total Portfolio Value: $1.5B (23 stocks)
• New Position: $ADRX ($134M)
• Biggest Add: $ALKS (+63% shares)
• Sold Out: $DNTH

📊 More at www.elixstocks.com

Educational only. Not investment advice.

#13F #Investing
Bain Capital Life Sciences Investors: Q3 2026 13F portfolio changes
4 new positions, 2 sold out, 2 added to, 3 trimmed.
elixstocks.com
November 16, 2026 at 12:50 PM
Random Stock
Ticker: $DNTH
Company: Dianthus Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
# Employees: 92
Recent Close: $92.48
52-Week High: $117.88
52-Week High Date: 08-19-2026
% Off 52-Week High: -21.55%
52-Week Low: $34.29
November 13, 2026 at 6:00 PM
November 10, 2026 at 8:55 PM
🚨 $DNTH
RYAN SAVITZ, a Officer, filed a notice of intent to sell 124,042 shares of common stock, valued at approximately $10,671,333.26, on 11/09/2026.
SEC Filing: DNTH
Click to view the official SEC document.
www.sec.gov
November 9, 2026 at 10:05 PM
Dianthus Therapeutics: Q3 net loss $46.6M; cash and investments $1.244B, runway into 2030; CAPTIVATE timing set.

#$DNTH FAQ + PDF report: www.merlintrader.com/dianthus-the...
November 5, 2026 at 2:16 PM
Dianthus Therapeutics $DNTH reported Q3 2026 EPS of -$0.81, beating the -$0.96 estimate by 15.6%. Revenue of $1.2M beat the $450,928 estimate by 168.3%.

https://fundspec.ai/s/DNTH/earnings
Pick a trader profile and get signals tuned to how you actually trade.
November 4, 2026 at 11:45 PM
🚨 $DNTH
On November 4, 2026, Dianthus Therapeutics, Inc. issued a press release announcing the Company’s financial results for the quarter ended September 30, 2026. A copy of this press release is furnished as Exhibit 99.1 and is incorporated herein by reference.
SEC Filing: DNTH
Click to view the official SEC document.
www.sec.gov
November 4, 2026 at 9:06 PM
www.stocktitan.net
November 2, 2026 at 10:00 PM
www.stocktitan.net
November 2, 2026 at 9:01 PM
Dianthus Therapeutics, Inc. /DE/ ($DNTH) – New 13G stake

• Holder: Vanguard Capital Management
• Stake: 0 → 5.08% (about $235M)
• About 13G: a passive investor, not seeking to influence the company

📊 More at www.elixstocks.com

Educational only. Not investment advice.

#Investing #Stocks
Vanguard Capital Management LLC: 5.08% of Dianthus Therapeutics, Inc. /DE/ ($DNTH)
Filed Oct 30. Who filed, the stake, and how it changed.
elixstocks.com
October 30, 2026 at 8:15 PM
$DNTH — Roth initiates coverage with Buy, price target $113.

Information only — not investment advice.

https://www.merlintrader.com/dianthus-therapeutics-dnth-stock-hub/
October 27, 2026 at 7:31 PM
Latest company news, October 1, 2026: Dianthus presented the CAPTIVATE interim analysis orally at AANEM. December guidance for MoMeNtum topline data was reiterated.

https://www.merlintrader.com/dianthus-therapeutics-dnth-stock-hub/
Dianthus Therapeutics $DNTH | December MMN Catalyst
Dianthus Therapeutics analysis of claseprubart, December MMN data, Phase 3 studies, cash runway, competition and clinical risks.
www.merlintrader.com
October 13, 2026 at 4:09 AM
BioPharmCatalyst Watchlist: Top Phase 3 biotech catalysts for the next 6 months. Key tickers: XENE, OCGN, IRON, RNAC, DNTH, LXRX, HELP, RZLT, PCVX, MANE. More: biopharmcatalyst.com www.biopharmcatalyst.com/news/2026/se...
September 25, 2026 at 8:15 PM
🚨 $DNTH
CARR EDWARD (CHIEF ACCOUNTING OFFICER) sold 20,000 shares at an average price of $101.3823 per common share. (Date: 2026-09-17)
SEC Filing: DNTH
Click to view the official SEC document.
www.sec.gov
September 18, 2026 at 8:47 PM
September 11, 2026 at 2:14 PM
JPMorgan starts #$DNTH at Overweight, $135 target. Lead drug claseprubart plus $1.2B cash into 2030. notreload.xyz/xy/jpmorgan-...
JPMorgan Puts $135 Target on DNTH After Starting Coverage
Lead drug claseprubart (also known as DNTH103) plus $1.2B cash into 2030.
notreload.xyz
September 11, 2026 at 3:52 PM
Dianthus (DNTH) Piles Up Clinical Wins While Its Losses Widen
Dianthus (DNTH) Piles Up Clinical Wins While Its Losses Widen - BeyondLink
On August 4, Dianthus Therapeutics (NASDAQ:DNTH) reported second-quarter 2026 results alongside a stack of pipeline updates that touched nearly every program
beyondlink.live
September 6, 2026 at 10:06 AM
September 4, 2026 at 1:46 PM
Dianthus raises $673.5M in public offering, selling 8.5M shares at $81 with full overallotment

$DNTH 8-K → https://filingdiff.com/ticker/DNTH/0001193125-26-103053/
June 5, 2026 at 2:40 AM
really enjoy your work
somehow reminds me of the work of GE (Tony) Fogg depicted in this post fro a few years ago bsky.app/profile/dnth...
#InternationalMicroorganismDay
“There is nothing, Sir, too little for so little a creature as man. It is by studying the little things that we attain the great art as having as little misery and as much happiness as possible" Samuel Johnson

Snow microbes by GE (Tony) Fogg
August 25, 2026 at 11:50 AM
just reposted with an apology -
bsky.app/profile/dnth...
Sea level rise has doubled in last 30 years - now around 0.5 cm per year (or 0.2 inch per year) 😱

This replaces my earlier erroneous re-post that recklessly got the units wrong. This important message does not need folks (who should know better) making stupid mistakes about the units - my apologies
The rate of global mean sea level rise has increased from ~2.1 mm/year in 1993 to ~4.5 mm/year in 2023. www.nature.com/articles/s43...
January 4, 2026 at 10:19 AM
In most years we have a bit more snow for this seasonal post:
bsky.app/profile/dnth...
Last #HelsinkiBikeCommute of 2023 for me today
……..phew
December 15, 2025 at 10:05 AM
Not every day is so splendid 🤣 e.g. bsky.app/profile/dnth...
“Filthy” is the only way to describe the #HelsinkiBikeCommute this morning
Raining, 1 oC and gravel paths turned to mud sponges - 😀
October 31, 2025 at 12:52 AM
The equinox was only the other day but already the #HelsinkiBikeCommute is down to 0 oC 🥶….but still lovely
#WinterCycling is starting
September 25, 2025 at 7:53 AM